Erratum: Molecular markers of endometrial carcinoma detected in uterine aspirates (International Journal of Cancer (2011) 129:11 (2435-2444) DOI: 10.1002/ijc.25901);Molecular markers of endometrial carcinoma detected in uterine aspirates

International Journal of Cancer

Volumn 129, Issue 10, 2011, Pages 2435-2444

  Colas, Eva ^a,b   Perez, Cristina ^c   Cabrera, Silvia ^a   Pedrola, Nuria ^a   Monge, Marta ^a   Castellvi, Josep ^a   Eyzaguirre, Fernando ^a   Gregorio, Jesus ^a   Ruiz, Anna ^a   Llaurado, Marta ^a   Rigau, Marina ^a   Garcia, Marta ^a   Ertekin, Tugçe ^a   Montes, Melania ^a   Lopez Lopez, Rafael ^d   Carreras, Ramon ^e   Xercavins, Jordi ^a,b   Ortega, Alicia ^f   Maes, Tamara ^c   Rosell, Elisabet ^c   Doll, Andreas ^a   Abal, Miguel ^a,d   Reventos, Jaume ^a,b   Gil Moreno, Antonio ^a,b   more..

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c ORYZON GENOMICS   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e HOSPITAL DEL MAR   (Spain)

^f QF Bayer   (Spain)

Author keywords

endometrial cancer; minimally invasive screening; molecular biomarkers; uterine aspirate

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE 1; ADAPTOR RELATED PROTEIN COMPLEX 1 MU 2 SUBUNIT; CINGULIN; DECORIN; DISCOIDIN DOMAIN RECEPTOR TYROSINE KINASE 1; EGF CONTAINING FIBULIN LIKE EXTRACELLULAR MATRIX PROTEIN 2; EPS8 LIKE2 PROTEIN; FAST KINASE DOMAIN 1 PROTEIN; GEM INTERACTING PROTEIN; I KAPPA B KINASE EPSILON; PHOSPHORYLASE KINASE GAMMA 2; PROLYL 4 HYDROXYLASE BETA POLYPEPTIDE; PTPRF INTERACTING PROTEIN BINDING PROTEIN 2; PURINERGIC P2X4 RECEPTOR; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 7; RING FINGER PROTEIN 183; SIRTUIN 6; SUPPRESSOR OF CYTOKINE SIGNALING 2; TIGHT JUNCTION PROTEIN 3; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE PROCEDURE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; UTERINE CERVIX CYTOLOGY; UTERUS FLUID; WESTERN BLOTTING;

EID: 80052970243     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27540     Document Type: Erratum

References (16)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96. (Pubitemid 351521864)
2. Baekelandt MM, Castiglione M; ESMO Guidelines Working Group. Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20: 29-31.
3. Abal M, Llaurado M, Doll A, Monge M, Colas E, Gonzalez M, Rigau M, Alazzouzi H, Demajo S, Castellvi J, Garcia A, Ramon y Cajal S, et al. Molecular determinants of invasion in endometrial cancer. Clin Transl Oncol 2007; 9: 272-7.
4. Baldi P, Long AD,. A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes. Bioinformatics 2001; 17: 509-19. (Pubitemid 32600497)
5. Monge M, Doll A, Colas E, Gil-Moreno A, Castellvi J, Garcia A, Colome N, Perez-Benavente A, Pedrola N, Lopez-Lopez R, Dolcet X, Ramon y Cajal S, et al. Subtractive proteomic approach to the endometrial carcinoma invasion front. J Proteome Res 2009; 8: 4676-84.
6. Francis JA, Weir MM, Ettler HC, Qiu F, Kwon JS,. Should preoperative pathology be used to select patients for surgical staging in endometrial cancer? Int J Gynecol Cancer 2009; 19: 380-4.
7. Gull B, Karlsson B, Milsom I, Granberg S,. Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol 2003; 188: 401-8. (Pubitemid 36253637)
8. Fleischer AC, Wheeler JE, Lindsay I, Hendrix SL, Grabill S, Kravitz B, MacDonald B,. An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms. Am J Obstet Gynecol 2001; 184: 70-5.
9. Harry VN, Deans H, Ramage E, Parkin DE, Gilbert FJ,. Magnetic resonance imaging in gynecological oncology. Int J Gynecol Cancer 2009; 19: 186-93.
10. Basu S, Li G, Alavi A,. PET and PET-CT imaging of gynecological malignancies: present role and future promise. Expert Rev Anticancer Ther 2009; 9: 75-96.
11. Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, Colas E, Llaurado M, Alazzouzi H, Planaguma J, Lohmann MA, Garcia J, et al. Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol 2008; 108: 221-9. (Pubitemid 351179637)
12. Sugiyama Y, Dan S, Yoshida Y, Akiyama F, Sugiyama K, Hirai Y, Matsuura M, Miyata S, Ushijima M, Hasumi K, Yamori T,. A large-scale gene expression comparison of microdissected, small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissue. Clin Cancer Res 2003; 9: 5589-600. (Pubitemid 37499479)
13. Risinger JI, Maxwell GL, Chandramouli GV, Jazaeri A, Aprelikova O, Patterson T, Berchuck A, Barrett JC,. Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res 2003; 63: 6-11. (Pubitemid 36070410)
14. Planaguma J, Diaz-Fuertes M, Gil-Moreno A, Abal M, Monge M, Garcia A, Baro T, Thomson TM, Xercavins J, Alameda F, Reventos J,. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma. Cancer Res 2004; 64: 8846-53. (Pubitemid 39665488)
15. Yurkovetsky Z, Ta'asan S, Skates S, Rand A, Lomakin A, Linkov F, Marrangoni A, Velikokhatnaya L, Winans M, Gorelik E, Maxwell GL, Lu K, et al. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin. Gynecol Oncol 2007; 107: 58-65. (Pubitemid 47464542)
16. Smith RA, Cokkinides V, Brawley OW,. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2009; 59: 27-41.